CHICAGO, Dec. 5, 2011 /PRNewswire/ -- CME Group, the
world's leading and most diverse derivatives marketplace, today
announced that it set new monthly records for clearing interest
rate swaps (IRS) and credit default swaps (CDS). For the
month of November, the company cleared $61.9
billion in combined OTC IRS and CDS volume, a 36 percent
increase over the previous record monthly total of $45.5 billion set in October 2011.
As of November 30, 2011, the
company has cleared more than $153
billion in OTC IRS and CDS through its multi-asset class
clearing solution since launch, including over $130 billion of buy side notional.
Additionally, open interest stood at $115.7
billion in IRS and $15.9
billion in CDS.
The company also announced the strong performance of its newly
launched OTC products, including Euro-denominated IRS which has
cleared euro 27.6 billion since it
launched on October 17, and the CDX
High Yield Indices which have cleared $2.3
billion since they launched on November 7. CME
Group further expanded its IRS offering today, with the launch of
British Pound and Canadian dollar-denominated IRS.
"We are very pleased with the strong support we're receiving
from buy side firms solidifying our position as the leading OTC
clearing service by U.S. customer volume," said Laurent Paulhac,
CME Group Managing Director, OTC Products & Services. "We
continue to aggressively expand our product offering based on
specific client demand. The success of our new IRS and CDS products
validates our customer driven approach to building out our
multi-asset class solution."
"Goldman Sachs is pleased to partner with CME Group in order to
serve our clients as both an execution counterparty and clearing
member for CME's OTC products," said Michael Dawley, Co-Head of Global Derivative
Clearing Services at Goldman Sachs. "CME's recent increase in
customer volume illustrates the buy side's desire to leverage OTC
clearing. Goldman Sachs is firmly committed to supporting our
clients' OTC derivatives clearing needs, and will continue to work
with CME Group to build out its OTC clearing business."
"RBS plc is pleased to have garnered the leadership role of the
first bank approved by the CME as a direct clearing member for OTC
derivatives," said Henson Orser, Head of USD Rates Sales. "We are
very supportive of the early adopters that use the CME to reduce
bilateral counterparty exposure, particularly in this environment
of heightened credit uncertainty."
To learn more about CME Group's OTC clearing offering, visit our
resources on IRS and CDS.
As the world's leading and most diverse derivatives marketplace,
CME Group (www.cmegroup.com) is where the world comes to manage
risk. CME Group exchanges offer the widest range of global
benchmark products across all major asset classes, including
futures and options based on interest rates, equity indexes,
foreign exchange, energy, agricultural commodities, metals, weather
and real estate. CME Group brings buyers and sellers
together through its CME Globex® electronic trading platform and
its trading facilities in New York
and Chicago. CME Group also operates CME Clearing, one of the
world's leading central counterparty clearing providers, which
offers clearing and settlement services for exchange-traded
contracts, as well as for over-the-counter derivatives transactions
through CME ClearPort®. These products and services ensure that
businesses everywhere can substantially mitigate counterparty
credit risk in both listed and over-the-counter derivatives
markets.
CME Group is a trademark of CME Group Inc. The Globe Logo, CME,
Globex and Chicago Mercantile Exchange are trademarks of Chicago
Mercantile Exchange Inc. CBOT and the Chicago Board of Trade are trademarks of the
Board of Trade of the City of
Chicago, Inc. NYMEX, New York Mercantile Exchange and
ClearPort are registered trademarks of New York Mercantile
Exchange, Inc. COMEX is a trademark of Commodity Exchange,
Inc. All other trademarks are the property of their
respective owners. Further information about CME Group (NASDAQ:
CME) and its products can be found at www.cmegroup.com.
CME-G
SOURCE CME Group